Your Article Summary
FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09
An important assay used to aid in the diagnosis of rheumatoid arthritis will soon be available on Abbott's ARCHITECT immunoassay analyzers. The FDA has granted 510(k) clearance for an antibody cyclic–citrulinated peptide, or anti–CCP assay, to run on the world class systems.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Companys TAP Technology
ImmunoGen, Inc., 11/20/09
Genzyme Announces Results of Phase 2/3 Trial of Advanced Phosphate Binder
Genzyme, 11/19/09
Par pharmaceutical receives final approval to market generic ultram er
Par Pharmaceutical, 11/17/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Medtronic Introduces 3D Recon Service to Enhance Endovascular Treatment of Aortic Aneurysms
Medtronic, 11/20/09
Philips developing digital pathology solutions
Canadian Healthcare Technology, 11/20/09
New director at CHUM hired from France
Canadian Healthcare Technology, 11/20/09
Article Search
Sponsor


See Latest Articles


